The GRAFT Study: Gut RecolonizAtion by Fecal Transplantation

NCT03621657 PHASE2 COMPLETED Results posted

The primary objective of this study is to compare the gut microbiota and clinical outcomes of oral FMT during antibiotic treatment, immediately following antibiotic treatment, and placebo. The second objective is to assess the safety and feasibility of daily oral Fecal Microbiome Transplant (FMT) as a treatment option.

Details

Lead sponsor	University of Wisconsin, Madison
Phase	PHASE2
Status	COMPLETED
Enrolment	1
Start date	Thu Mar 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Feb 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Clostridium Difficile Infection
• C.Difficile Diarrhea
• CDI

Interventions

• Low Dose FMT Capsule DE
• Single Dose FMT Capsule DE
• Placebo oral capsule

Countries

United States